But in 1991 Bristol-Myers contracted with the National Cancer Institute to develop the drug anyway, in exchange for exclusivemarketingrights that expired last year.
Corporations can legally become associated with the London 2012 Games in two ways: First, multinational firms may seek exclusivemarketingrights through The Olympic Partner program (TOP).